Greatanalysis matching up Dr. Ngo’s heart damaging cancer drugs study with thosedrugs reported by RAC as showing cardio-protection and cancer killing synergy.
I note there are two drugs on the list that RAC has announced cancer killing synergy, but not cardio-protection, with. Hopefully, this will mean that bisantrene will also be found to be cardio-protective with:
- Epirubicin - the cancer killing synergy was announced as part of the anthracycline synergy study reported on 22November 2021 - https://hotcopper.com.au/threads/ann-breakthrough-zantrene-heart-protection-discovery.6435902/- Olaparib - the cancer killing synergy was announced as part of the MD Anderson study reported on 23 February 2022 - https://hotcopper.com.au/threads/ann-md-anderson-preclinical-aml-study-on-zantrene-published.6600203/
Cardioprotection thread, page-221
-
- There are more pages in this discussion • 395 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
